Ningbo Jingyan Chiyang Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Ningbo Jingyan Chiyang Technology Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SFJY. The owner is based in Zhejiang.

(5-37), Bldg 079, No.222 Huizhan Road,

Yinzhou Dist, Ningbo,

Zhejiang 315100 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SFJY
SFJY
Registered 2023
SFJY
SFJY
Abandoned 2021

Trademark Classifications

Ningbo Jingyan Chiyang Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Ningbo Jingyan Chiyang Technology Co., Ltd. have?

Ningbo Jingyan Chiyang Technology Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does Ningbo Jingyan Chiyang Technology Co., Ltd. file in?

Ningbo Jingyan Chiyang Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Ningbo Jingyan Chiyang Technology Co., Ltd.'s most well-known trademarks?

Ningbo Jingyan Chiyang Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as SFJY. These are among 1 currently registered trademark in the portfolio.

What is Ningbo Jingyan Chiyang Technology Co., Ltd.'s trademark registration success rate?

Ningbo Jingyan Chiyang Technology Co., Ltd. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.